Journal article icon

Journal article

Group B meningococcal vaccine science and policy.

Abstract:
Capsular group B Neisseria meningitidis is one of the leading causes of death in developed countries. A new vaccine (4CMenB) has recently been developed which was found to have an acceptable safety profile in clinical studies and to be immunogenic. This review examines the evidence supporting the licensure of the 4CMenB vaccine and discusses recommendations for its use.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Publisher copy:
10.1016/j.jinf.2015.04.021

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Paediatrics
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Paediatrics
Publisher:
Elsevier Publisher's website
Journal:
The Journal of infection Journal website
Volume:
71 Suppl 1
Pages:
S15-S20
Publication date:
2015-06-05
DOI:
EISSN:
1532-2742
ISSN:
0163-4453
URN:
uuid:4f57b1bc-3ff3-4b91-a627-0b8ae7fd4f17
Source identifiers:
521728
Local pid:
pubs:521728

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP